(0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Walter E. Washington Convention Center

2015 年 06 月 14 日 2:30 下午 - 2015 年 06 月 18 日 6:45 下午

801 Mount Vernon Place, NW, , Washington, DC 20001-3614 , USA

DIA 2015 51st Annual Meeting: Develop. Innovate. Advance.

Full conference and one-day registrants will have access to presentation PDFs through Friday, December 18, 2015 <A href="http://www.diaglobal.org/Flagship-Meetings/DIA-Annual-Meeting/Meeting-Program/ePac-Presentations-Access.aspx">Review Presentations </A>

概览

DIA 2015 51st Annual Meeting: Develop.  Innovate.  Advance.

The DIA 2015 51st Annual Meeting brings together a global community of life sciences professionals at all levels and across all disciplines all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

The DIA Annual Meeting provides the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.

谁应该参加？

The DIA Annual Meeting is designed for individuals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, and related medical products.

学习目标

  • Provide a global unbiased platform to raise the level of discussion to facilitate innovation that will change the future of health care
  • Provide comprehensive coverage of the full development and life cycle management of process for all health care products
  • Offer a holistic and integrated approach to the development life cycle management of regulated health care products

项目委员会

  • Christopher P. Austin, MD
    Christopher P. Austin, MD CEO Partner
    Flagship Pioneering, United States
  • Michael Rosenblatt, MD
    Michael Rosenblatt, MD Chief Medical Officer
    Flagship Pioneering, United States
  • J. Lynn Bass, PharmD, RPh
    J. Lynn Bass, PharmD, RPh Medical Affairs Lead
    Mesoblast, United States
  • Daniel Bollag, PhD
    Daniel Bollag, PhD Chief Strategy Officer
    Ocular Therapeutics, United States
  • Linda Bowen, MSc, RAC
    Linda Bowen, MSc, RAC Adjunct Professor
    Temple University Pharmacy School, United States
  • Jonca Bull, MD
    Jonca Bull, MD Vice President, Regulatory Consulting
    PPD, United States
  • Bill Byrom, PhD
    Bill Byrom, PhD Vice President, Product Intelligence and Positioning; Principal, eCOA Science
    Signant Health , United Kingdom
  • Joy A. Cavagnaro, PhD
    Joy A. Cavagnaro, PhD President
    Access BIO, United States
  • Karla Childers, MS
    Karla Childers, MS Vice President, Bioethics, Policy & Partnerships
    Johnson & Johnson, United States
  • Leah Christl, PhD
    Leah Christl, PhD Exec Director, Global Biosimilars Regulatory Affairs & Regulatory & R&D Policy
    Amgen, United States
  • Betsy Fallen, RN
    Betsy Fallen, RN Consultant
    BAFallen Consulting LLC, United States
  • Ron Fitzmartin, PhD, MBA
    Ron Fitzmartin, PhD, MBA Principal Consultant
    Decision Analytics, United States
  • Michael Folkendt, MS
    Michael Folkendt, MS Associate Director for Regulatory Affairs, OPRO, OPQ, CDER
    FDA, United States
  • Elizabeth E. Garrard, PharmD
    Elizabeth E. Garrard, PharmD Executive Vice President, Global Safety Operations
    Clinipace Worldwide, United States
  • Jonathan Haddad, MPH
    Jonathan Haddad, MPH HIV Disease Area Head, Clinical Statistics
    GlaxoSmithKline, United States
  • Martin Harvey Allchurch, LLM
    Martin Harvey Allchurch, LLM Head of International Affairs
    European Medicines Agency, Netherlands
  • Jonathan Solomon Helfgott, MS
    Jonathan Solomon Helfgott, MS Senior Lecturer, Faculty, & Program Coordinator,
    Johns Hopkins University, United States
  • Deborah J. Henderson, MSN
    Deborah J. Henderson, MSN Head, Global Regulatory Policy
    Merck & Co., Inc., United States
  • Rima Izem, PhD
    Rima Izem, PhD Associate Director Statistical Methodology
    Novartis, Switzerland
  • Janet Jenkins-Showalter
    Janet Jenkins-Showalter Head, US Regulatory Policy
    Genentech, A Member of the Roche Group, United States
  • John Kamp
    John Kamp Washington Counsel
    Coalition For Healthcare Communication (CHC), United States
  • Ellen Kelso
    Ellen Kelso Head, Knowledge Strategy
    KSE Ltd., United States
  • Lynn King, MHA
    Lynn King, MHA Consultant
    United States
  • Agnes Klein, MD
    Agnes Klein, MD Senior Medical Advisor
    Health Canada, Canada
  • Stephen Knowles, MD, MRCP
    Stephen Knowles, MD, MRCP Chief Medical Officer
    Halozyme Therapeutics, United States
  • Mark Kryah, PMP
    Mark Kryah, PMP Executive Director, Program Team Leader, Program and Portfolio Management
    Ultragenyx Pharmaceutical Inc., United States
  • JeanMarie Markham
    JeanMarie Markham Chief Executive Officer
    Clinlogix, United States
  • Philomena McArthur, JD
    Philomena McArthur, JD VP, Global Policies, Procedures & Training, Health Care Compliance & Privacy
    Johnson & Johnson International, United States
  • Ann Meeker-O'Connell, MS
    Ann Meeker-O'Connell, MS Executive Director, Monitoring Excellence Head
    Novartis, United States
  • Jon Meyer, MBA, MSc
    Jon Meyer, MBA, MSc Co-Founder and Managing Member
    Life Science Strategy Group, LLC, United States
  • Mary Murray, MBA, MS
    Mary Murray, MBA, MS Family Caregiver
    Independent Consultant, United States
  • Bob Muzerall
    Bob Muzerall Vice President, Sales & Sales Training
    AMPLEXOR Life Sciences, LLC, United States
  • Nancy Bradish Myers, JD
    Nancy Bradish Myers, JD CEO and Founder
    Catalyst Healthcare Consulting, United States
  • Jane Myles, MSc
    Jane Myles, MSc Program Director
    Jemtech Co, United States
  • Roger Nosal, PhD
    Roger Nosal, PhD Vice President, Head of Global CMC
    Pfizer Inc, United States
  • Lisa Palladino-Kim, EdD, MS
    Lisa Palladino-Kim, EdD, MS Lecturer / Director of Capstone
    Rutgers School of Health Professions Clin Research Mgmt, United States
  • Pradip Paul, MD, MS
    Pradip Paul, MD, MS Consultant
    Strategic Pharmacovigilance and Risk Management, United States
  • Kirsten H. Paulson, MS, RAC
    Kirsten H. Paulson, MS, RAC
    Pfizer, Inc., United States
  • Julia Petses, PharmD
    Julia Petses, PharmD Global Head, Medical Information Excellence and SEC Established and Rare Franchi
    Novartis, United States
  • Christine Pierre, RN
    Christine Pierre, RN President
    Society for Clinical Research Sites, United States
  • James E. Polli, PhD
    James E. Polli, PhD Prof, Ralph F Shangraw/Noxell Endowed Chair in Industrial Pharmacy/Pharmaceutic
    University of Maryland School of Pharmacy, United States
  • Sarah Pope Miksinski, PhD
    Sarah Pope Miksinski, PhD Executive Director, CMC Regulatory Affairs
    Gilead Sciences, United States
  • Badri Rengarajan, MD
    Badri Rengarajan, MD Life Sciences
    Jazz Pharmaceuticals, United States
  • Matthew D. Rotelli, PhD, MS
    Matthew D. Rotelli, PhD, MS Vice President, Bioethics
    Eli Lilly and Company, United States
  • Leslie Sam
    Leslie Sam President
    Leslie Sam and Associates, LLC, United States
  • Abdul J. Sankoh, PhD, MA, MS
    Abdul J. Sankoh, PhD, MA, MS Vice President, Data Science
    Sage Therapeutics, Inc. , United States
  • Suzanne Sensabaugh, MBA, MS
    Suzanne Sensabaugh, MBA, MS President and Principal Consultant
    HartmannWillner LLC, United States
  • Ashley F. Slagle, PhD, MS
    Ashley F. Slagle, PhD, MS Principal, Scientific and Regulatory Consulting
    Aspen Consulting, LLC, United States
  • Nancy Pire Smerkanich, DrSc, MS
    Nancy Pire Smerkanich, DrSc, MS Assistant Professor Regulatory & Quality Sciences
    University of Southern California School of Pharmacy, United States
  • Maureen Smith, MEd
    Maureen Smith, MEd Member
    Clinical Trials Ontario College of Lived Experience, Canada
  • William B. Smith, MD
    William B. Smith, MD CEO
    Alliance for Multispecialty Research, LLC , United States
  • Ling Su, PhD
    Ling Su, PhD Research Fellow
    Yeehong Business School, China
  • Sameer Thapar, PharmD, RPh
    Sameer Thapar, PharmD, RPh Global Pharmacovigilance Director
    Oracle Health Sciences, United States
  • Toshiyoshi Tominaga, PhD
    Toshiyoshi Tominaga, PhD Life Science Department, Advisor
    SunFlare Co., Ltd, Japan
  • Linda Fossati Wood
    Linda Fossati Wood President
    MedWrite, Inc., United States

注册方法

Registration override should work.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表，了解DIA的观点和事件。